Capn4 is a marker of poor clinical outcomes and promotes nasopharyngeal carcinoma metastasis via nuclear factor-κB-induced matrix metalloproteinase 2 expression

por Zheng, Pei-Chan, Chen, Xiong, Zhu, Hong-Wu, Zheng, Wei, Mao, Li-Hua, Lin, Cheng, Liu, Jing-Nan, Zheng, Ming
Publicado 2014